Top Markets
#1 CoW Protocol CoW Protocol +65.62%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +24.17%
#5 Nockchain Nockchain +15.44%
#6 Velvet Velvet +15.00%
#7 Humanity Humanity +14.65%
#8 The Black Bull The Black Bull +13.24%
#9 Tutorial Tutorial +12.75%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
CoW Protocol CoW Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Classifica tra le azioni #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Prezzo delle azioni
$0.00060315
Ultima sincronizzazione: 2024-09-27
Capitalizzazione di mercato
$1.65M
Variazione (1 giorno)
19.64%
Variazione (1 anno)
0.00%
Paese
SE
Scambia Amniotics AB (publ) (AMNI)

Categoria

Healthcare
Rapporto P/B per Amniotics AB (publ) (AMNI)
Rapporto P/B al August 2026 TTM: 0.98
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Amniotics AB (publ), il rapporto P/B attuale (TTM) è 0.98. Alla fine del 2022, era pari a 43.73.
Storico del rapporto P/B per Amniotics AB (publ) da 2018 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.98 -40.17%
2023 1.63 -96.28%
2022 43.73 263.99%
2021 12.01 -34.02%
2020 18.21 -69.40%
2019 59.51 -75.80%
2018 245.87 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 550.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 540.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 254.92%
BE